Innovative juice drink could benefit circulation

Venture company, Provexis has agreed a joint venture with Nutrinnovator Holdings to develop a new heart-healthy drink. The drink will be the first of its kind: a juice drink containing a patented natural fruit extract which has been proven in human trials to 'thin' the blood and benefit the circulation.

Provexis collaborated with the Rowett Institute over a four year period to develop and clinically test a patented ingredient called CardioFlow.

It works by reducing the 'stickiness' of blood platelets which prevents them from self-aggregating and potentially initiating a fatal thrombus. The natural fruit-derived extract is proven to provide real health benefits without affecting the taste, and without the side-effects typically associated with aspirin. It is expected that development of a commercial product will be ready for UK launch in May 2005, and the joint venture plans to expand distribution into the US and Japan thereafter.